A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies (Q28348809)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies |
scientific article |
Statements
A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies (English)
C M Eng
M Banikazemi
R E Gordon
M Goldman
R Phelps
L Kim
A Gass
J Winston
S Dikman
S Brodie
C B Stacy
D Mehta
R Parsons
K Norton
1 February 2001
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference